Autoimmune Hepatitis

Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

Volumn , Issue , 2008, Pages 1089-1102

  Vergani, Diego ^a   Mieli Vergani, Giorgina ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autoimmune hepatitis; Elevated immunoglobulin g; Inflammatory liver disease; Non viral chronic hepatitis; Pathogenic mechanism

Indexed keywords

EID: 84889303651     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470691861.ch11b     Document Type: Chapter

References (57)

1. Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354(1), 54-66.
2. Manns MP, Vogel A (2006) Autoimmune hepatitis, from mechanisms to therapy. Hepatology 43(S1), S132-144.
3. Mieli-Vergani G, Vergani D (2002) Autoimmune hepatitis in children. Clin Liver Dis 6(3), 623-634.
4. Vergani D, Mieli-Vergani G (2003) Autoimmune hepatitis. Autoimmun Rev 2(5), 241-247.
5. Vergani D, Mieli-Vergani G (2004) Autoimmune hepatitis. Minerva Gastroenterol Dietol 50(2), 113-123.
6. Vergani D, Mieli-Vergani G (2004) Autoimmune hepatitis and sclerosing cholangitis. Autoimmunity 37(4), 329-332.
7. Zum Buschenfelde KH (2003) Autoimmune hepatitis: 'Hepatitis sui generis'. J Hepatol 38(2), 130-135.
8. Reuben A (2003) A sheep in wolf's clothing. Hepatology 38(6), 1596-1601.
9. Waldeström J (1950) Leber, Blutproteine und Nahrungseiweiss. Dtsch Z Verdau Staffwechselkr 15, 113-119.
10. Joske RA, King WE (1955) The LE-cell phenomenon in active chronic viral hepatitis. Lancet 269(6888), 477-480.
11. Leoni A (1954) [The specificity of LE phenomenon.] Minerva Med 45(30), 1022-1027.
12. Mackay IR, Taft LI, Cowling DC (1956) Lupoid hepatitis. Lancet 271(6957), 1323-1326.
13. Mackay IR, Weiden S, Hasker J (1965) Autoimmune hepatitis. Ann NY Acad Sci 124(2), 767-780.
14. Homberg JC, Abuaf N, Bernard O et al. (1987) Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of 'autoimmune' hepatitis. Hepatology 7(6), 1333-1449.
15. Johnson PJ, McFarlane IG (1993) Meeting report: International Autoimmune Hepatitis Group. Hepatology 18(4), 998-1005.
16. Alvarez F, Berg PA, Bianchi FB et al. (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31(5), 929-938.
17. Boberg KM, Aadland E, Jahnsen J et al. (1998) Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33(1), 99-103.
18. Feld JJ, Dinh H, Arenovich T et al. (2005) Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 42(1), 53-62.
19. Manns MP, Luttig B, Obermayer-Straub P (1998) Autoimmune hepatitis. In: Rose NR, Mackay IR (eds) The Autoimmune Diseases, 3rd edn. Burlington, MA: Academic Press, pp. 511-525.
20. Primo J, Merino C, Fernandez J et al. (2004) [Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain)]. Gastroenterol Hepatol 27(4), 239-243.
21. Gregorio GV, Portmann B, Reid F et al. (1997) Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 25(3), 541-547.
22. Vergani D, Alvarez F, Bianchi FB et al. (2004) Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 41(4), 677-683.
23. Ma Y, Okamoto M, Thomas MG et al. (2002) Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 35(3), 658-664.
24. Ma Y, Gaken J, McFarlane BM et al. (1997) Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease. Gastroenterology 112(2), 483-492.
25. Czaja AJ, Carpenter HA (2001) Autoimmune hepatitis In: Macsween RNM, Burt AD, Portmann BC (eds) Pathology of the Liver, 4th edn. London: Churchill Livingstone, pp. 415-434.
26. Gregorio GV, Portmann B, Karani J et al. (2001) Autoimmune hepatitis/ sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33(3), 544-553.
27. Donaldson PT (2002) Genetics in autoimmune hepatitis. Semin Liver Dis 22(4), 353-364.
28. Donaldson PT (2004) Genetics of autoimmune and viral liver diseases; understanding the issues. J Hepatol 41(2), 327-332.
29. Czaja AJ, Donaldson PT (2000) Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 174, 250-259.
30. Ma Y, Bogdanos DP, Hussain MJ et al. (2006) Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type-2. Gastroenterology in press.
31. Simmonds MJ, Gough SC (2004) Genetic insights into disease mechanisms of autoimmunity. Br Med Bull 71, 93-113.
32. Liston A, Lesage S, Gray DH et al. (2005) Genetic lesions in T-cell tolerance and thresholds for autoimmunity. Immunol Rev 204, 87-101.
33. Jaeckel E (2002) Animal models of autoimmune hepatitis. Semin Liver Dis 22(4), 325-338.
34. Peters MG (2002) Animal models of autoimmune liver disease. Immunol Cell Biol 80(1), 113-116.
35. Lohse AW, Meyer zum Buschenfelde KH (1993) Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression. Clin Exp Immunol 94(1), 163-167.
36. Lohse AW, Kogel M, Meyer zum Buschenfelde KH (1995) Evidence for spontaneous immunosuppression in autoimmune hepatitis. Hepatology 22(2), 381-388.
37. Lapierre P, Djilali-Saiah I, Vitozzi S et al. (2004) A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens. Hepatology 39(4), 1066-1074.
38. Christen U, Rhode A, Johnson E et al. (2004) Development of an animal model for autoimmune hepatitis: breaking of self-tolerance in the CYP2D6 humanized mouse by viral infection. Hepatology 162A.
39. Mackay IR (2002) Hepatoimmunology: a perspective. Immunol Cell Biol 80(1), 36-44.
40. Vergani D, Choudhuri K, Bogdanos DP et al. (2002) Pathogenesis of autoimmune hepatitis. Clin Liver Dis 6(3), 727-737.
41. Muratori L, Parola M, Ripalti A et al. (2000) Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 46(4), 553-561.
42. Kerkar N, Choudhuri K, Ma Y et al. (2003) Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 170(3), 1481-1489.
43. Aichele P, Bachmann MF, Hengartner H et al. (1996) Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol Rev 152, 21-45.
44. Wen L, Ma Y, Bogdanos DP et al. (2001) Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr Mol Med 1(3), 379-389.
45. Longhi MS, Ma Y, Bogdanos DP et al. (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41(1), 31-37.
46. Lohr H, Manns M, Kyriatsoulis A et al. (1991) Clonal analysis of liverinfiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol 84(2), 297-302.
47. Lohr HF, Schlaak JF, Lohse AW et al. (1996) Autoreactive CD4+ LKMspecific and anticlonotypic T-cell responses in LKM-1 antibodypositive autoimmune hepatitis. Hepatology 24(6), 1416-1421.
48. Johnson PJ (1997) Treatment of autoimmune hepatitis. Gut 41(1), 3-4.
49. Czaja AJ, Freese DK (2002) Diagnosis and treatment of autoimmune hepatitis. Hepatology 36(2), 479-497.
50. Seela S, Sheela H, Boyer JL (2005) Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy. Liver Int 25(4), 734-739.
51. Heneghan MA, Norris SM, O'Grady JG et al. (2001) Management and outcome of pregnancy in autoimmune hepatitis. Gut 48(1), 97-102.
52. Wang KK, Czaja AJ, Beaver SJ et al. (1989) Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis. Hepatology 10(1), 39-43.
53. Alvarez F, Ciocca M, Canero-Velasco C et al. (1999) Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 30(2), 222-227.
54. Vergani D, Mieli-Vergani G (2002) Autoimmunity after liver transplantation. Hepatology 36(2), 271-276.
55. Mieli-Vergani G, Vergani D (2004) De novo autoimmune hepatitis after liver transplantation. J Hepatol 40(1), 3-7.
56. Kerkar N, Hadzic N, Davies ET et al. (1998) De-novo autoimmune hepatitis after liver transplantation. Lancet 351(9100), 409-413.
57. Aguilera I, Sousa JM, Gavilan F et al. (2004) Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl 10(9), 1166-1172.